Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Aviva, Silbergeld"'
Publikováno v:
The Israel Medical Association journal : IMAJ. 21(8)
Publikováno v:
Anthropologischer Anzeiger. 69:255-259
UNLABELLED The differential growth effects of hGH and IGF-I on the upper/lower (U/L) body segment in relation to height (Ht) were analyzed in 15 patients with isolated Growth hormone deficiency (IGHD,:7M, 8F) mean age 5.0 +/- 3.2 (SD) years treated w
Autor:
Daniel Landau, Andrey Podshyvalov, Yael Segev, Leonid Katchko, Michel Afargan, Aviva Silbergeld, Moshe Phillip
Publikováno v:
Kidney International. 60:505-512
A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse . Background PTR-3173 (S) is a novel somatostatin analogue that has been found to exert a prolonged inhibitory action on the growth hormone (GH)-insulin-l
Publikováno v:
Endocrine. 16:01-06
Puberty is associated with an increase in the plasma concentration of sex steroids, growth hormone (GH), and insulin-like growth factor-1 (IGF-1). Gonadal steroid hormones are important for the normal pubertal growth spurt and skeletal growth. The me
Publikováno v:
European Journal of Endocrinology. :626-630
A minority of patients with Laron syndrome have normal serum GH binding protein (GHBP), indicating that the defect is elsewhere than in the extracellular domain of the GH receptor. We have evaluated the effect of long-term IGF-I treatment on serum IG
Autor:
Aviva Silbergeld, Sharon Koren, Nathaniel Laor, Rina Eshet, Ronit Weizman, Leo Wolmer, Sofia Eldar, Paz Toren, Dov Inbar, Raphael Weitz, Ahuva Reiss
Publikováno v:
Clinical Neuropharmacology. 20:264-269
The aim of this study was to assess the growth hormone (GH) axis in methylphenidate (MPH)-treated and untreated boys with attention-deficit and hyperactivity disorder (ADHD), by evaluating serum GH, GH-binding protein (GHBP) activity, and insulin-lik
Publikováno v:
European Journal of Endocrinology. 134:716-719
Klinger B, Silbergeld A, Deghenghi R, Frenkel J, Laron Z. Desensitization from long-term intranasal treatment with hexarelin does not interfere with the biological effects of this growth hormonereleasing peptide in short children. Eur J Endocrinol 19
Publikováno v:
Acta Endocrinologica. 128:144-149
Insulin-like growth factor binding protein-3 (IGFBP-3) is the major carrier of insulin-like growth factor I (IGF-1) in serum, and its production is growth hormone (GH) dependent. It is unclear whether in humans IGFBP-3 production is directly regulate
Autor:
Aviva Silbergeld, Zvi Laron
Publikováno v:
Laron Syndrome-From Man to Mouse ISBN: 9783642111822
Untreated patients with Laron syndrome have acromicria, such as small hands and feet, and organomicria (i.e. small internal organs).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c87ebb744118cdf30024d47c55922c3c
https://doi.org/10.1007/978-3-642-11183-9_25
https://doi.org/10.1007/978-3-642-11183-9_25
Autor:
Aviva Silbergeld, S. N. McCutcheon, Hugh T. Blair, Andrzej Surus, G. R. Ambler, Bernhard H. Breier, Peter D. Gluckman
Publikováno v:
Acta Endocrinologica. 126:155-161
We evaluated the interrelationship between, and regulation of, the hepatic growth hormone receptor and serum GH binding protein (GH BP) in pigs treated with recombinant porcine growth hormone (rpGH). Infant and pubertal male pigs (N = 5 per group) re